Temporal trends in mortality from 1999 to 2020 in patients aged over 25 years with heart failure and cardiogenic shock
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20262697Keywords:
Heart failure, CDC MCD, CS, Age-adjusted mortality rate, Retrospective studyAbstract
Background: Heart failure (HF) is a major cause of mortality and its association with cardiogenic shock (CS) remains underexplored. Understanding this relationship is essential to identify high-risk populations and develop targeted public health interventions. Aim was to evaluate mortality trends in HF, where CS is a contributing cause of death by using the Centers for Diseases Control and Prevention (CDC) multiple causes of death by (MCD) database.
Methods: A retrospective original research study was conducted using the CDC MCD database to assess mortality trends between 1999 and 2020 in individuals >25 years in the United States. Deaths from congestive HF (ICD-10, I50.0), left ventricular failure (i50.1) and HF, unspecified (ICD-10, I50.9) as underlying cause and CS (ICD-10, R57.0) as contributor cause were selected. Data were stratified by gender, race, geographic region and place of death. Age-adjusted mortality rates (AAMR) and annual percentage change (APC) were calculated.
Results: A total of 14901 deaths were recorded. The AAMR for HF with CS showed a decline from 1999 to 2009 (APC- -4.84%), an increase, 2009 - 2012 (APC +3.92%) and decline, 2012 to 2020 (APC: 2.68%) with the highest mortality observed in males (56.6%), white individuals (76.7%), and metropolitan areas (81.50%). Trends showed an increase in AAMR in females (APC: +15.48 %) after 2012, black individuals with APC +22.10% after 2010 demonstrating disparities.
Conclusions: Mortality trends in HF have changed with rising disparities in gender and race, indicating need for cardiac interventions and improved health care access.
References
Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J Cardiac Failure. 2021;27(4):387-413.
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272-87.
Ruiz-García A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martínez E, Turégano-Yedro M, Pallarés-Carratalá V. Heart failure prevalence rates and its association with other cardiovascular diseases and chronic kidney disease: SIMETAP-HF Study. J Clin Med. 2023;12(15):4924.
Sarma D, Jentzer JC. Cardiogenic shock: pathogenesis, classification, and management. Crit Care Clin. 2024;40(1):37-56.
Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, et al. A. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. J Heart Lung Transplantation. 2024;43(2):189-203.
Sinha SS, Rosner CM, Tehrani BN. Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-year outcomes. Circ Heart Fail. 2022;15(6):e009279.
Böhm M. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. Thoracic Cardiovasc Surgeon. 1998;46(2):270-6.
Ye P, Duan W, Leng YQ, Wang YK, Tan X, Wang WZ. DPP3: from biomarker to therapeutic target of cardiovascular diseases. Front Cardiovasc Med. 2022;9:974035.
Cupo P, Figueiredo AB, Antonio Filho P, Pintya AO, Júnior GA, Caligaris F, et al. Acute left ventricular dysfunction of severe scorpion envenomation is related to myocardial perfusion disturbance. Int J Cardiol. 2007;116(1):98-106.
Sharma S, Burton LV, Beier K. Papillary Muscle Rupture. InStatPearls. StatPearls Publishing. 2024.
Abraham JA, Blumer V, Burkhoff DA, Pahuja M, Sinha SS, Rosner C, et al. Heart failure-related cardiogenic shock: pathophysiology, evaluation and management considerations: review of heart failure-related cardiogenic shock. J Cardiac Failure. 2021;27(10):1126-40.
Patel AK, Hollenberg SM. Cardiovascular failure and cardiogenic shock. InSeminars in respiratory and critical care medicine. Thieme Med. 2011;32(05):598-606.
Yandrapalli S, Sanaani A, Harikrishnan P, Aronow WS, Frishman WH, Lanier GM, et al. Cardiogenic shock during heart failure hospitalizations: age-, sex-, and race-stratified trends in incidence and outcomes. Am Heart J. 2019;213:18-29.
Puymirat E, Fagon JY, Aegerter P, Hauw-Berlemont C, Boissier F, Diehl JL, et al. 0130: Mortality related to cardiogenic shock in critically ill patients in France, 1997-2012. Arch Cardiovasc Dis Supplements. 2016;8(1):110.
Durand E, Grinda JM, Bruneval P. Cardiogenic shock in a young woman revealing juvenile haemochromatosis. Heart. 2003;89(8):870.
Mehta H, Kurpad K, Pahuja M, Sutaria N, Afonso L. Trends in Treatment and Outcomes of Cardiogenic Shock in the Adult Congenital Heart Disease Population: A Nationwide Analysis From 2007-2017. Circulation. 2020;142(3):A16458.
Agarwal M, Agrawal S, Garg L, Mohananey D, Garg A, Bhatia N, et al. National trends in the incidence, management, and outcomes of heart failure complications in patients hospitalized for ST-segment elevation myocardial infarction. Mayo Clin Proceedings. 2017;1(1):26-36.
Glynn PA, Molsberry R, Harrington K, Shah NS, Petito LC, Yancy CW, et al. Geographic variation in trends and disparities in heart failure mortality in the United States, 1999 to 2017. J Am Heart Associat. 2021;10(9):e020541.
Dam Lauridsen M, Rorth R, Lindholm MG, Kjaergaard J, Schmidt M, Torp-Pedersen C, et al. P5012 Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study. Euro Heart J. 2019;40(1):ehz746-0190.
Goldberg RJ, Makam RC, Yarzebski J, McManus DD, Lessard D, Gore JM. Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2016;9(2):117-25.
Petersen LT, Riddersholm S, Andersen DC, Polcwiartek C, Lee CJ, Lauridsen MD, et al. Temporal trends in patient characteristics, presumed causes, and outcomes following cardiogenic shock between 2005 and 2017: a Danish registry-based cohort study. Euro Heart J Acute Cardiovasc Care. 2021;10(9):1074-83.
Belfioretti L, Marini M, Francioni M, Battistoni I, Angelini L, Matassini M, et al. C25 Temporal Trend Mortality and in-Hospital Mortality Predictors in an Ischemic Cardiogenic Shock Population: A 10 Years Single-Centre Retrospective Study. Euro Heart J Supplements. 2023;25(D):D11.
Olanipekun T, Abe T, Effoe VS, Fatuyi M, Egbuche O. Racial Disparities in the Incidence and Outcomes of Peripartum Cardiomyopathy Complicated by Cardiogenic Shock. Circulation. 2021;144(1):A14118.
Downloads
Published
How to Cite
Issue
Section
